Your browser doesn't support javascript.
loading
HER2 as a novel therapeutic target for cervical cancer.
Oh, Doo-Yi; Kim, Seokhwi; Choi, Yoon-La; Cho, Young Jae; Oh, Ensel; Choi, Jung-Joo; Jung, Kyungsoo; Song, Ji-Young; Ahn, Suzie E; Kim, Byoung-Gie; Bae, Duk-Soo; Park, Woong-Yang; Lee, Jeong-Won; Song, Sangyong.
Afiliação
  • Oh DY; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim S; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Choi YL; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Cho YJ; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Oh E; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Choi JJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Jung K; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Song JY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn SE; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Kim BG; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Bae DS; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park WY; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • Lee JW; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
  • Song S; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.
Oncotarget ; 6(34): 36219-30, 2015 Nov 03.
Article em En | MEDLINE | ID: mdl-26435481

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo do Útero / Receptor ErbB-2 Limite: Adult / Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo do Útero / Receptor ErbB-2 Limite: Adult / Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article